GLP-1 receptor agonists for obesity: eligibility across 99 countries. uri icon

authors

  • Yoo, Sang Gune K
  • Bovet, Pascal
  • Brant, Luisa C C
  • Cuschieri, Sarah
  • Damasceno, Albertino
  • Farzadfar, Farshad
  • Fawwad, Asher
  • Geldsetzer, Pascal
  • Hambleton, Ian R
  • Houehanou, Corine
  • Howitt, Christina
  • Teufel, Felix
  • J Rgensen, Jutta
  • González-Rivas, Juan P
  • Labadarios, Demetre
  • Marcus, Maja
  • Martins, Joao
  • Mwalim, Omar
  • Nieto-Martínez, Ramfis
  • Odili, Augustine N
  • Orazumbekova, Binur
  • Perman, Gastón
  • Theilmann, Michaela
  • Quesnel-Crooks, Sarah
  • Moghaddam, Sahar Saeedi
  • Sewpal, Ronel
  • Sousa-Uva, Mafalda
  • Sulola, Mubarak A
  • Venkataraman, Kavita
  • Vollmer, Sebastian
  • Xueling, Sim
  • Atun, Rifat
  • Banegas, José R
  • Si, Yajuan
  • Franco, Juan V A
  • Arnott, Clare
  • Chandiwana, Nomathemba
  • Huffman, Mark D
  • Davies, Justine
  • Ali, Mohammed K
  • Flood, David
  • Manne-Goehler, Jennifer
  • Toure, Elhadji A
  • Aryal, Krishna
  • Bärnighausen, Till
  • Bait, Abdul
  • Barreto, Marta

publication date

  • February 2026